The aim of this study was to characterize the patterns of prostate cancer recurrence after brachytherapy (BT) using [18F]DCFPyL PSMA PET/CT imaging.
Patients were selected from an ongoing prospective institutional trial, investigating the utility of [18F]DCFPyL PSMA PET/CT in recurrent prostate cancer (NCTXXXXXXXX).